Nivagen Pharmaceuticals, Inc.
Swanand Kelkar has extensive experience in quality assurance and quality control within the pharmaceutical industry, currently serving as Sr Manager Quality Assurance at Nivagen Pharmaceuticals, Inc. since June 2019, following a role as Quality Manager. Previous positions include Deputy Manager - QA at Shilpa Medicare and Asst. Manager QC at Wockhardt Limited. Swanand's background also includes various roles in quality control at SUN PHARMA, Nicholas Piramal India Limited, ALEMBIC LIMITED, and Aristo Pharmaceuticals Pvt. Ltd. Educational qualifications comprise a Diploma in Regulatory Affairs from the Bioinformatic Institute of India and a Master’s degree in Biochemistry from Devi Ahilya Vishwavidyalaya.
This person is not in any offices
Nivagen Pharmaceuticals, Inc.
Nivagen is engaged in the development, acquisition, and sales of generic prescription drugs and over the counter products for the North American market. It envisions to deliver high-quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.The US genericprescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in the next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, they can provide cost savings to the consumer while creating value for all members of the supply chain.